In news that should surprise no one, the Society for Evidence-Based Gender Medicine (SEGM) reports that the supposedly robust evidence base for puberty blockers is not just weak: it fails to replicate. The original Dutch studies on using off-label cancer drugs to halt puberty in gender-confused children claimed doing so afforded modest improvements in m…
Keep reading with a 7-day free trial
Subscribe to Mary Harrington to keep reading this post and get 7 days of free access to the full post archives.